NEUROBO PHARMACEUTICALS INC's ticker is NRBO and the CUSIP is 64132R107. A total of 31 filers reported holding NEUROBO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $11,000 | -88.8% | 24,056 | -18.7% | 0.00% | – |
Q2 2021 | $98,000 | -46.7% | 29,576 | -15.5% | 0.00% | – |
Q4 2020 | $184,000 | -51.6% | 34,987 | -48.3% | 0.00% | – |
Q3 2020 | $380,000 | -55.9% | 67,616 | -36.8% | 0.00% | -100.0% |
Q2 2020 | $861,000 | -33.7% | 106,922 | +5.4% | 0.00% | -66.7% |
Q1 2020 | $1,299,000 | – | 101,418 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hayden Royal, LLC | 20,642 | $91,000 | 0.05% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 173,202 | $762,000 | 0.01% |
SG3 Management, LLC | 50,000 | $220,000 | 0.01% |
Ameritas Investment Partners, Inc. | 378 | $2,000 | 0.00% |
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 9,817 | $43,000 | 0.00% |
UBS Group AG | 2,841 | $13,000 | 0.00% |
AMERICAN INTERNATIONAL GROUP, INC. | 3,926 | $17,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 11,642 | $51,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 13,762 | $61,000 | 0.00% |
NORTHERN TRUST CORP | 78,993 | $348,000 | 0.00% |